ALLMedicine™ Pleurectomy Center

May 13th, 2022 - PRIMARY OBJECTIVE: I. To detect an improvement in overall survival with the addition of adjuvant hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) to surgery and chemotherapy compared to surgery and chemotherapy alone. SECONDARY...

May 10th, 2022 - For patients with this type of cancer, the standard of care is treatment with chemotherapy. Radiation therapy is typically not used. This is because radiation to the entire lining of the lung has many side effects that are often severe including d...

May 9th, 2022 - Approach Considerations Despite general agreement on the management of pneumothorax, a full consensus about management of initial or recurrent pneumothorax does not exist. Professional societies differ in their approach to management and hospitali...

May 7th, 2022 - There are limited small, single-institution observational studies on the role of surgery in patients with biphasic mesothelioma. Herein we report a series of 147 consecutive patients with biphasic mesothelioma treated over 11 years in a high-volum...

Mar 31st, 2022 - The ENSURE trial is an open label, single center, phase 1, feasibility study. Sixteen adult patients diagnosed with resectable epithelioid malignant pleural mesothelioma (MPM) will be enrolled following first-line chemotherapy. Before standard-of-...

May 13th, 2022 - PRIMARY OBJECTIVE: I. To detect an improvement in overall survival with the addition of adjuvant hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) to surgery and chemotherapy compared to surgery and chemotherapy alone. SECONDARY...

May 10th, 2022 - For patients with this type of cancer, the standard of care is treatment with chemotherapy. Radiation therapy is typically not used. This is because radiation to the entire lining of the lung has many side effects that are often severe including d...

Mar 31st, 2022 - The ENSURE trial is an open label, single center, phase 1, feasibility study. Sixteen adult patients diagnosed with resectable epithelioid malignant pleural mesothelioma (MPM) will be enrolled following first-line chemotherapy. Before standard-of-...

Sep 29th, 2021 - The aim is to introduce a new therapeutic method of intracavitary chemotherapy (cisplatin) combined with a fibrin carrier (Vivostat®) after pleurectomy/decortication or extrapleural pneumonectomy in a phase I and II study for Malignant Pleural Mes...

May 27th, 2021 - A randomized Phase II trial to test whether the addition of intraoperative Photofrin-mediated photodynamic therapy to radical pleurectomy and post-operative chemo.improves OS in the treatment of patients with epithelioid MPM. Subjects assigned to ...

Oct 6th, 2021 - Prasad S. Adusumilli, MD Deputy Chief, Thoracic Service Memorial Sloan Kettering Cancer Center Although malignant pleural mesothelioma (MPM) remains a rare disease, Memorial Sloan Kettering Cancer Center has considerable experience with th...

Sep 13th, 2021 - Neoadjuvant treatment with cisplatin/pemetrexed plus atezolizumab (Tecentriq), followed by maintenance atezolizumab, demonstrated early efficacy with acceptable safety in patients with resectable pleural mesothelioma, according to data from an upd...

Mar 2nd, 2021 - Guidelines on malignant pleural mesothelioma were published on February 4, 2021 by the Spanish Society of Medical Oncology in Clinical Guides in Oncology.[1] Diagnosis and Staging Genomic studies are not recommended in routine clinical practice bu...

Dec 5th, 2020 - %u25BA NORWAY Hopes for Trastuzamab Use in Endometrial Cancer The link between HER-2/neu receptors and endometrial cancer is growing stronger, and this may point the way to treatment with existing therapies, according to research cond...

May 7th, 2019 - Treatment with high doses of radiotherapy may significantly boost survival for patients with mesothelioma, according to new findings. New results from a randomized clinical trial show that patients who were treated with aggressive radiotherapy wer...